Business Segments · Cost of Sales
Emerging Markets Segment — Cost of Sales
Viatris Emerging Markets Segment — Cost of Sales decreased by 17.0% to $219.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.2%, from $212.80M to $219.60M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026
How to read this metric
A decrease relative to sales suggests improved manufacturing efficiency or favorable product mix, while an increase may signal rising input costs or supply chain inefficiencies.
Detailed definition
This metric includes the direct costs associated with manufacturing, sourcing, and distributing pharmaceutical products...
Peer comparison
Standard segment-level COGS reported by pharmaceutical manufacturers to show regional production efficiency.
Metric ID:
vtrs_segment_emerging_markets_segment_cost_of_salesHistorical Data
7 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $265.30M | $271.60M | $249.00M | $212.80M | $240.40M | $264.60M | $219.60M |
| QoQ Change | — | +2.4% | -8.3% | -14.5% | +13.0% | +10.1% | -17.0% |
| YoY Change | — | — | — | -19.8% | -11.5% | +6.3% | +3.2% |
Range$212.80M – $271.60M
CAGR-11.8%
Avg YoY Growth-5.5%
Median YoY Growth-4.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's emerging markets segment — cost of sales?
- Viatris (VTRS) reported emerging markets segment — cost of sales of $219.60M in Q1 2026.
- How has Viatris's emerging markets segment — cost of sales changed year-over-year?
- Viatris's emerging markets segment — cost of sales increased by 3.2% year-over-year, from $212.80M to $219.60M.
- What does emerging markets segment — cost of sales mean?
- The direct costs incurred to produce and deliver the products sold in the emerging markets segment.